A compound of Formula: Wherein: R 1 is hydrogen, C 1-3 alkyl, CH 2 OH, CH 2 -O-CH 3, CH 2 OCH 2 Ph, CH 2 CN, CN, halo or C OCH 3; R 2 is independently hydrogen, CN, CF 3, halo, SO 2 C 1-3 alkyl, C 1-3 alkyl or CΞCH; R 3 is hydrogen, C 1-2 alkyl, CF 3 or OH; R 4 is hydrogen, halo or C 1-3 alkyl; X is CR 4 or N; A is (CH 2) n - Het; or A is (CH 2) n -(CR a R b)-(CH 2) m -Het; R a is hydrogen or C 1-3 alkyl, wherein the C 1-3 alkyl may be further substituted with one or more halos; R b is C 1-3 alkyl; or R a and R b together with the carbon atom they are attached form a C 3-6 cycolalkyl group; or one of the carbon atoms in the C 3-6 cycolalkyl group formed by R a and R b may be replaced with oxygen to form an oxetane, tetrahydrofuryl or tetrahydropyranyl group; or one of the carbon atoms in the C 3-6 cycolalkyl group formed by R a and R b may be replaced with nitrogen to form a pyrrolidinyl or piperidinyl group; Het is: wherein Het may be substituted by one, two or three substituents chosen from: halo, C 1 - 5 alkyl, CN, CH 2 F, CHF 2, CF 3, C 3-6 cycloalkyl, (CH 2) n -O-C 1-3 alkyl, (CH 2) n -phenyl, (CH 2) n -pyridyl, pyrimidinyl, pyrazinyl, CH(CH 3)-O-C 1-3 alkyl, CH -C 1-5 alkyl, C(CH 3) 2 - R 5, C N(CH 3) p, N(C 1-3 alkyl) p, NH 2, C NH 2, oxetane, oxetane-CH 3, tetrahydrofuryl, tetrahydropyranyl, morpholinyl, or pyrazolyl; wherein the phenyl, pyrazolyl, and pyridyl substituent on the Het may be further substituted by one or two substituents chosen from: halo, CN, OCH 3, C 1-3 alkyl or CF 3; and the C 1-5 alkyl and C 3-6 cycolalkyl substituent on the Het may be further substituted by CN or OH; R 5 is CN, O-C 1-4 alkyl, (CH 2) m - OH, (CH 2) p - O - C - O - C 1-5 alkyl, or O-(CH 2) p -O -R 6; R 6 is C 1-4 alkyl or P 2 (CH 3) 2; n is independently 0, 1 or 2; m is independently 0, 1 or 2; p is independently 1 or 2; and y is 1, 2 or 3; or a pharmaceutically acceptable salt thereof. R 1 is hydrogen, C 1-3 alkyl, CH 2 OH, CH 2 -O-CH 3, CH 2 OCH 2 Ph, CH 2 CN, CN, halo or C OCH 3; R 2 is independently hydrogen, CN, CF 3, halo, SO 2 C 1-3 alkyl, C 1-3 alkyl or CΞCH; R 3 is hydrogen, C 1-2 alkyl, CF 3 or OH; R 4 is hydrogen, halo or C 1-3 alkyl; X is CR 4 or N; A is (CH 2) n - Het; or A is (CH 2) n -(CR a R b)-(CH 2) m -Het; R a is hydrogen or C 1-3 alkyl, wherein the C 1-3 alkyl may be further substituted with one or more halos; R b is C 1-3 alkyl; Het is: wherein Het may be substituted by one, two or three substituents chosen from: halo, C 1 - 5 alkyl, CN, CH 2 F, CHF 2, CF 3, C 3-6 cycloalkyl, (CH 2) n -O-C 1-3 alkyl, (CH 2) n -phenyl, (CH 2) n -pyridyl, pyrimidinyl, pyrazinyl, CH(CH 3)-O-C 1-3 alkyl, CH -C 1-5 alkyl, C(CH 3) 2 - R 5, C N(CH 3) p, N(C 1-3 alkyl) p, NH 2, C NH 2, oxetane, oxetane-CH 3, tetrahydrofuryl, tetrahydropyranyl, morpholinyl, or pyrazolyl; wherein the phenyl, pyrazolyl, and pyridyl substituent on the Het may be further substituted by one or two substituents chosen from: halo, CN, OCH 3, C 1-3 alkyl or CF 3; and the C 1-5 alkyl and C 3-6 cycolalkyl substituent on the Het may be further substituted by CN or OH; R 5 is CN, O-C 1-4 alkyl, (CH 2) m - OH, (CH 2) p - O - C - O - C 1-5 alkyl, or O-(CH 2) p -O -R 6; R 6 is C 1-4 alkyl or P 2 (CH 3) 2; n is independently 0, 1 or 2; m is independently 0, 1 or 2; p is independently 1 or 2; and y is 1, 2 or 3;